AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Working Capital

Annual Working Capital:

$161.03M-$221.60M(-57.92%)
December 31, 2024

Summary

  • As of today, AMLX annual working capital is $161.03 million, with the most recent change of -$221.60 million (-57.92%) on December 31, 2024.
  • During the last 3 years, AMLX annual working capital has risen by +$76.91 million (+91.44%).
  • AMLX annual working capital is now -57.92% below its all-time high of $382.62 million, reached on December 31, 2023.

Performance

AMLX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Quarterly Working Capital:

$165.47M-$32.75M(-16.52%)
June 1, 2025

Summary

  • As of today, AMLX quarterly working capital is $165.47 million, with the most recent change of -$32.75 million (-16.52%) on June 1, 2025.
  • Over the past year, AMLX quarterly working capital has dropped by -$91.17 million (-35.53%).
  • AMLX quarterly working capital is now -57.41% below its all-time high of $388.49 million, reached on September 30, 2023.

Performance

AMLX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

AMLX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-57.9%-35.5%
3Y3 Years+91.4%-12.4%
5Y5 Years+10000.0%+2521.0%

AMLX Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-57.9%+91.4%-57.4%+19.1%
5Y5-Year-57.9%>+9999.0%-57.4%+2521.0%
All-TimeAll-Time-57.9%>+9999.0%-57.4%+2521.0%

AMLX Working Capital History

DateAnnualQuarterly
Jun 2025
-
$165.47M(-16.5%)
Mar 2025
-
$198.21M(+23.1%)
Dec 2024
$161.03M(-57.9%)
$161.03M(-15.8%)
Sep 2024
-
$191.35M(-25.4%)
Jun 2024
-
$256.64M(-19.5%)
Mar 2024
-
$318.89M(-16.7%)
Dec 2023
$382.62M
$382.62M(-1.5%)
Sep 2023
-
$388.49M(+6.9%)
DateAnnualQuarterly
Jun 2023
-
$363.31M(+7.7%)
Mar 2023
-
$337.44M(+0.6%)
Dec 2022
$335.52M(+298.9%)
$335.52M(+141.4%)
Sep 2022
-
$138.98M(-26.5%)
Jun 2022
-
$188.97M(-20.5%)
Mar 2022
-
$237.78M(+182.7%)
Dec 2021
$84.11M(+1232.4%)
$84.11M(+1232.4%)
Dec 2020
$6.31M(+575.7%)
$6.31M
Dec 2019
-$1.33M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual working capital?
  • What is the all-time high annual working capital for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual working capital year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly working capital?
  • What is the all-time high quarterly working capital for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly working capital year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual working capital?

The current annual working capital of AMLX is $161.03M

What is the all-time high annual working capital for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual working capital is $382.62M

What is Amylyx Pharmaceuticals, Inc. annual working capital year-on-year change?

Over the past year, AMLX annual working capital has changed by -$221.60M (-57.92%)

What is Amylyx Pharmaceuticals, Inc. quarterly working capital?

The current quarterly working capital of AMLX is $165.47M

What is the all-time high quarterly working capital for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly working capital is $388.49M

What is Amylyx Pharmaceuticals, Inc. quarterly working capital year-on-year change?

Over the past year, AMLX quarterly working capital has changed by -$91.17M (-35.53%)
On this page